GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: example 48 [WO2012056478]
                                 
                                                         
                            Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: This compound is reported as an inhibitor of calcium release-activated calcium (CRAC) channel activity [2]. CRAC channels contain Orai1 (the pore-forming subunit) and stromal interaction molecule 1 (STIM1, which senses Ca2+ levels in the endoplasmic reticulum), and they mediate influx of Ca2+ ions into T cells in response to antigen engagement. CRAC function inhibitors have anti-inflammatory potential via blocking NFAT-mediated T cell activation. The chemical structure was claimed in Lupin Limited's 2012 patent WO2012056478A1 [1].
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
| Bioactivity Comments | 
| Compound 36 inhibits antigen-activated IL-2 and TNFα release from T cells, and is active in in vivo rheumatoid arthritis models [2]. Inhibits CRAC-channel mediated store-operated calcium entry (SOCE) with an in vitro IC50 of 11 nM [2]. | 
| Selectivity at ion channels | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
                                                                        
                                                                         
  | 
                                                                ||||||||||||||||||||||||||||||||||